Cargando…

The state of telemedicine for persons with Parkinson's disease

PURPOSE OF REVIEW: The COVID-pandemic has facilitated the implementation of telemedicine in both clinical practice and research. We highlight recent developments in three promising areas of telemedicine: teleconsultation, telemonitoring, and teletreatment. We illustrate this using Parkinson's d...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Bergh, Robin, Bloem, Bastiaan R., Meinders, Marjan J., Evers, Luc J.W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	MOVEMENT DISORDERS: Edited by Per Svenningsson
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279892/ https://www.ncbi.nlm.nih.gov/pubmed/33990100 http://dx.doi.org/10.1097/WCO.0000000000000953

Ejemplares similares

Ataxin-2 gene: a powerful modulator of neurological disorders
por: Laffita-Mesa, Jose Miguel, et al.
Publicado: (2021)

From trials to clinical practice: Temporal trends in the coverage of specialized allied health services for Parkinson's disease
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Deep brain stimulation in Parkinson’s disease: state of the art and future perspectives
por: França, Carina, et al.
Publicado: (2022)

Features of GBA-associated Parkinson’s disease at presentation in the UK Tracking Parkinson’s study
por: Malek, Naveed, et al.
Publicado: (2018)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
por: Aviles-Olmos, Iciar, et al.
Publicado: (2014)

Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
por: Swallow, Diane M A, et al.
Publicado: (2016)

The prediagnostic phase of Parkinson's disease
por: Noyce, Alastair John, et al.
Publicado: (2016)

Combining biomarkers for prognostic modelling of Parkinson’s disease
por: Vijiaratnam, Nirosen, et al.
Publicado: (2022)

Stability of mild cognitive impairment in newly diagnosed Parkinson's disease
por: Lawson, Rachael A, et al.
Publicado: (2017)

Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?
por: Doherty, Karen M, et al.
Publicado: (2013)

Bone health in Parkinson's disease: a systematic review and meta-analysis
por: Torsney, Kelli M, et al.
Publicado: (2014)

Visual hallucinations in the differential diagnosis of parkinsonism
por: Bertram, Kelly, et al.
Publicado: (2012)

How I treat Parkinson's disease
por: Barbosa, Egberto Reis, et al.
Publicado: (2022)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results
por: Noyce, Alastair J, et al.
Publicado: (2014)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank
por: Jacobs, Benjamin Meir, et al.
Publicado: (2020)

Clinical implications of early caudate dysfunction in Parkinson’s disease
por: Pasquini, Jacopo, et al.
Publicado: (2019)

Cortical thinning is associated with disease stages and dementia in Parkinson's disease
por: Zarei, Mojtaba, et al.
Publicado: (2013)

Bilateral adaptive deep brain stimulation is effective in Parkinson's disease
por: Little, Simon, et al.
Publicado: (2016)

Brain iron deposition is linked with cognitive severity in Parkinson’s disease
por: Thomas, George Edward Calver, et al.
Publicado: (2020)

Validation of new diagnostic criteria for fatigue in patients with Parkinson disease
por: Siciliano, Mattia, et al.
Publicado: (2022)

A composite clinical motor score as a comprehensive and sensitive outcome measure for Parkinson’s disease
por: Lo, Christine, et al.
Publicado: (2022)

Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
por: Sauerbier, Anna, et al.
Publicado: (2021)

Using ‘dead or dependent’ as an outcome measure in clinical trials in Parkinson's disease
por: McGhee, David, et al.
Publicado: (2015)

Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
por: Xiao, Bin, et al.
Publicado: (2016)

Comparative whole transcriptome analysis of Parkinson’s disease focusing on the efficacy of zonisamide
por: Naito, Tatsuhiko, et al.
Publicado: (2022)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study
por: Kazmi, Hiba, et al.
Publicado: (2021)

Efficacy of intensive multidisciplinary rehabilitation in Parkinson’s disease: a randomised controlled study
por: Ferrazzoli, Davide, et al.
Publicado: (2018)

Long‐term independence and quality of life after subthalamic stimulation in Parkinson disease
por: Castrioto, Anna, et al.
Publicado: (2022)

Prognostic predictors relevant to end-of-life palliative care in Parkinson’s disease and related disorders: a systematic review
por: Akbar, Umer, et al.
Publicado: (2021)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

Visual dysfunction is a better predictor than retinal thickness for dementia in Parkinson’s disease
por: Hannaway, Naomi, et al.
Publicado: (2023)

Parkinson disease male-to-female ratios increase with age: French nationwide study and meta-analysis
por: Moisan, Frédéric, et al.
Publicado: (2016)

Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018)

Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson’s disease
por: Stoker, Thomas B, et al.
Publicado: (2020)

Prevalence and genotype–phenotype correlations of GBA‐related Parkinson disease in a large Chinese cohort
por: Ren, Jingru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nrrmr26cnhdmdiro1c9ua08ho2